The company, which is launching the product in the US, said approval has been granted in the strengths of 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg. (Source: The Economic Times Healthcare and Biotech News)
Dr Reddy's Laboratories gets USFDA nod for generic version of Suboxone
Previous post: Indivior subpoenaed by California on opioid addiction treatment
Next post: FDA Approves First Generic Under-the-Tongue Suboxone
